2016 CSCC Travelling Lectureship

sponsored by
logo RGB 150x40



 Dr. Pranesh Chakraborty
Director, Newborn Screening Ontario
Physician, Section of Metabolism and Newborn Screening, Department of Pediatrics, CHEO
Medical Director, BORN Ontario
Associate Professor, Department of Pediatrics, Faculty of Medicine, University of Ottawa


Newborn Screening: The changing landscape

Screening newborns for rare diseases for which effective treatments are available is a crucial public health practice impacting thousands of Canadians. The expansion of population-wide newborn screening programs was named by the Centers for Disease Control and Prevention (CD) as one of the ten great public health achievements in the first ten years of the 21st century. This expansion was largely driven by major advances in screening technologies and has led to important gains in population health due to reductions in death and severe illness from rare genetic diseases. Horizon scanning has identified four major disruptors in newborn screening;
1. Genomic and metabolomic technologies
2. Information systems to merge and interpret data
3. Point of care tests that can be performed at the bedside or at home
4. A new industry and health research focus on developing personalized / rare disease treatments

Learning Objectives:
At the conclusion of this session, participants will be able to:
1)  Describe the current state of newborn screening
2) Recognize the factors that are causing change in the practice of newborn screening
3) Discuss the new paradigms that are emerging as a result of these factors


October 15 Jasper, AB  
October 17 Quebec City, QC  
October 25 Vancouver BC  
October 27 Toronto, ON  Program
November 14 Halifax, NS  
November 15 St. John's, NL